Evidence map›Paper›PMID 40401625›Full record

ArticleChembiochem : a European journal of chemical biology2025

Hazelnut: Explorations toward the Biocatalytic Synthesis of its Aroma Precursor.

Mireia Salvadó-Pau, Wolf-Dieter Fessner, Zvjezdana Findrik Blažević, Michael Breuer

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mireia Salvadó-PauDepartment of White Biotechnology Research - Biocatalysis, BASF SE, RGR/DB, Carl-Bosch-Strasse 38, 67056, Ludwigshafen am Rhein, Germany.ORCID https://orcid.org/0009-0004-2868-9513
Wolf-Dieter FessnerInstitut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Peter-Grünberg-Str. 4, 64287, Darmstadt, Germany.
Zvjezdana Findrik BlaževićFaculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000, Zagreb, Croatia.ORCID https://orcid.org/0000-0002-5312-8951
Michael BreuerDepartment of White Biotechnology Research - Biocatalysis, BASF SE, RGR/DB, Carl-Bosch-Strasse 38, 67056, Ludwigshafen am Rhein, Germany.ORCID https://orcid.org/0000-0002-6683-4003

Funding

European Union's Horizon 2020 research 956631
6 · The paper itself

Abstract

Biocatalysis gains significant industrial interest due to its controlled stereoselectivity and use of mild process conditions. Here, a biosynthetic route is proposed for the synthesis of filbertone (5-methyl-2-hepten-4-one, 1), which is the principal flavor compound of hazelnut. The enantiomeric purity of the industrially synthesized compound is defined, contrary to the natural aroma, which varies according to the source of the nut, extraction conditions, and treatments. The novel synthetic pathway for a hazelnut aroma precursor proposed here consists of a multienzyme cascade, which starts from the two amino acids D-Ile and L-Thr that are individually converted by enzyme catalysts, i.e., D-amino acid oxidase and threonine deaminase, followed by CC ligation of the obtained products, allowing a potentially sustainable production of the natural aroma. The most critical step is CC ligation, which uses two carbonyl compounds as starting material. This step is catalyzed by a regioselective transketolase (TK) that originates from Geobacillus stearothermophilus. The approach holds promise for the industrial production of natural hazelnut aroma precursors, addressing the growing demand in the aroma industry for synthesis methods that sustain the regulatory claims for natural compounds.

Indexed as

CorylusOdorantsBiocatalysisGeobacillus stearothermophilusStereoisomerismaromabiosynthesiscarboligationfilbertonethiamine diphosphate

Identifiers

PMID40401625
PMCPMC12432537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.